paxlovid pfizer - dofaq.co
Enough Paxlovid to treat Covid-19 in at-risk adults, but it is no longer free: MOH
The Straits Times - 16 Dec 2024
Enough Paxlovid to treat Covid-19 in at-risk adults, but it is no longer free: MOH ...
Pfizer readies its next-generation COVID-19 antiviral
C&EN - 10 Mar 2025
Pfizer readies its next-generation COVID-19 antiviral ...
Pfizer's Covid-19 drug powers strong quarterly profit as activist hovers
The Business Times - 29 Oct 2024
Pfizer's Covid-19 drug powers strong quarterly profit as activist hovers ...
Pfizer sticks to 2025 profit view as it shrugs off plunging Paxlovid sales with COVID infections in retreat
MarketWatch - 29 Apr 2025
Pfizer sticks to 2025 profit view as it shrugs off plunging Paxlovid sales with COVID infections in retreat ...
The unprecedented Paxlovid journey from milligrams to millions of patient doses during the Covid-19 pandemic
Nature - 20 Mar 2025
The unprecedented Paxlovid journey from milligrams to millions of patient doses during the Covid-19 pandemic ...
Pfizer profits dip on lower Paxlovid sales
Yahoo Finance - 29 Apr 2025
Pfizer profits dip on lower Paxlovid sales ...
Smaller US winter COVID wave adds pressure to Pfizer turnaround
Reuters - 03 Feb 2025
Smaller US winter COVID wave adds pressure to Pfizer turnaround ...
Paxlovid may not reduce hospitalization risk for vaccinated older adults
The Washington Post - 05 Mar 2025
Paxlovid may not reduce hospitalization risk for vaccinated older adults ...
Pfizer bumps up revenue outlook by $1.5B in Paxlovid rebound amid criticism from activist investor Starboard
Fierce Pharma - 29 Oct 2024
Pfizer bumps up revenue outlook by $1.5B in Paxlovid rebound amid criticism from activist investor Starboard ...
Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales
CNBC - 29 Oct 2024
Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales ...
Merck, Pfizer rebuff China’s push for deeper price cuts on Covid-19 drugs
The Straits Times - 25 Nov 2024
Merck, Pfizer rebuff China’s push for deeper price cuts on Covid-19 drugs ...
Pfizer CEO defends turnaround strategy as activist pressures management
Reuters - 29 Oct 2024
Pfizer CEO defends turnaround strategy as activist pressures management ...
Pfizer’s plunging Paxlovid sales impact revenue as COVID fades
MarketWatch - 29 Apr 2025
Pfizer’s plunging Paxlovid sales impact revenue as COVID fades ...
Pfizer harnesses COVID fluctuations to clinch Q4 gains as RSV vaccine sales plummet
Fierce Pharma - 04 Feb 2025
Pfizer harnesses COVID fluctuations to clinch Q4 gains as RSV vaccine sales plummet ...
Pfizer's Q3 Earnings Beat, Paxlovid Drives Sales Guidance Increase
Yahoo Finance - 29 Oct 2024
Pfizer's Q3 Earnings Beat, Paxlovid Drives Sales Guidance Increase ...
Pfizer sees steep 2023 fall in Covid-19-related sales, aims to bolster pipeline
The Straits Times - 22 Nov 2024
Pfizer sees steep 2023 fall in Covid-19-related sales, aims to bolster pipeline ...
Fixing the Achilles Heel of Pfizer’s Paxlovid for COVID-19 Treatment
ACS Publications - 05 Jul 2024
Fixing the Achilles Heel of Pfizer’s Paxlovid for COVID-19 Treatment ...
Pfizer Antiviral Paxlovid's Extended Use Shows Mixed Results for Long COVID Relief: Study
Yahoo Finance - 06 Jan 2025
Pfizer Antiviral Paxlovid's Extended Use Shows Mixed Results for Long COVID Relief: Study ...
Where do fake Covid-19 drugs come from?
The Straits Times - 22 Nov 2024
Where do fake Covid-19 drugs come from? ...